We are delighted to announce the agenda of the upcoming symposium organized and supported by CSL Behring at WFH 2024, Madrid, Spain: “Optimizing the patient journey in von Willebrand disease: Experiences and learnings as the navigator” Tuesday 23 April, 12:45–13:45 CET This congress will take place in-person at the IFEMA Convention Centre in Madrid, Spain. Join our faculty of experts, Nicola Curry \(hematologist, UK\), Heleen Eising \(gynecologist, The Netherlands\), Julia Rauscher \(patient advocate, Austria\), and Sunny Maini \(patient advocate, UK\), as they discuss the real-life experiences of stakeholders navigating the von Willebrand disease \(VWD\) diagnosis and care pathways. The session will aim to be inspirational for the audience, to shorten the route to diagnosis of and optimize the care for patients with VWD. Registration for WFH 2024 is still open, you can register here: https://lnkd.in/eJjXg\_ME
CSL Vifor Announces U.S. FDA Approval for Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-dependent Adult Patients
New oral therapy option developed by partner Akebia Therapeutics
CSL has Announced its 2024 Half Year Financial Results. Click here to read more →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and ProductsCSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL BehringCSL Seqirus. On the Front Line of Public Health Protection.
As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies, and the latest methods of production and distribution. Together with our partners we’re on the front line every day, working to help protect communities from seasonal influenza and global pandemic threats.
More About CSL SeqirusCSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?